Enzyme-based listericidal nanocomposites

Sci Rep. 2013:3:1584. doi: 10.1038/srep01584.

Abstract

Cell lytic enzymes represent an alternative to chemical decontamination or use of antibiotics to kill pathogenic bacteria, such as listeria. A number of phage cell lytic enzymes against listeria have been isolated and possess listericidal activity; however, there has been no attempt to incorporate these enzymes onto surfaces. We report three facile routes for the surface incorporation of the listeria bacteriophage endolysin Ply500: covalent attachment onto FDA approved silica nanoparticles (SNPs), incorporation of SNP-Ply500 conjugates into a thin poly(hydroxyethyl methacrylate) film; and affinity binding to edible crosslinked starch nanoparticles via construction of a maltose binding protein fusion. These Ply500 formulations were effective in killing L. innocua (a reduced pathogenic surrogate) at challenges up to 10(5) CFU/ml both in non-growth sustaining PBS as well as under growth conditions on lettuce. This strategy represents a new route toward achieving highly selective and efficient pathogen decontamination and prevention in public infrastructure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / pharmacology
  • Bacteriophages / enzymology*
  • Endopeptidases / administration & dosage*
  • Endopeptidases / chemistry
  • Listeria / cytology*
  • Listeria / drug effects*
  • Listeria / virology
  • Materials Testing
  • Nanocapsules / administration & dosage*
  • Nanocapsules / chemistry*
  • Nanocapsules / ultrastructure
  • Particle Size
  • Silicon Dioxide / chemistry*

Substances

  • Anti-Bacterial Agents
  • Nanocapsules
  • Silicon Dioxide
  • Endopeptidases
  • endolysin